Bailard Inc. Makes New $251,000 Investment in Viemed Healthcare, Inc. (NASDAQ:VMD)

Bailard Inc. bought a new position in Viemed Healthcare, Inc. (NASDAQ:VMD) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 32,022 shares of the company’s stock, valued at approximately $251,000.

Other large investors have also bought and sold shares of the company. State Board of Administration of Florida Retirement System purchased a new stake in Viemed Healthcare in the third quarter worth $67,000. DORCHESTER WEALTH MANAGEMENT Co purchased a new position in shares of Viemed Healthcare in the third quarter valued at $84,000. Ulland Investment Advisors LLC purchased a new position in shares of Viemed Healthcare in the third quarter valued at $85,000. Mackenzie Financial Corp purchased a new position in shares of Viemed Healthcare in the third quarter valued at $89,000. Finally, Violich Capital Management Inc. purchased a new position in shares of Viemed Healthcare in the fourth quarter valued at $177,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $8.31 on Monday. The stock has a market cap of $322.10 million, a PE ratio of 31.96 and a beta of 1.51. Viemed Healthcare, Inc. has a fifty-two week low of $5.90 and a fifty-two week high of $11.27. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.05 and a current ratio of 1.19. The stock has a fifty day moving average of $8.79 and a 200-day moving average of $8.03.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, March 6th. The company reported $0.09 earnings per share for the quarter. The company had revenue of $50.74 million during the quarter. Viemed Healthcare had a return on equity of 9.59% and a net margin of 5.60%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.